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Mechanism of catalysis and 
inhibition of Mycobacterium 
tuberculosis sapM, implications 
for the development of novel 
antivirulence drugs
paulina Fernandez-soto  1, Alexander J. e. Bruce1, Alistair J. Fielding  2, Jennifer s. Cavet1 & 
Lydia tabernero  1
Mycobacterium tuberculosis (Mtb) sapM is a secreted virulence factor critical for intracellular survival 
of the pathogen. the role of sapM in phagosome maturation arrest in host macrophages suggests its 
potential as a drug target to assist in the clearance of tuberculosis infection. However, the mechanism 
of action of sapM at the molecular level remains unknown. In this study, we provide new insights 
into the mechanism of catalysis, substrate specificity and inhibition of SapM, and we identify the 
critical residues for catalysis and substrate binding. Our findings demonstrate that SapM is an atypical 
monoester alkaline phosphatase, with a serine-based mechanism of catalysis probably metal-
dependent. Particularly relevant to SapM function and pathogenesis, is its activity towards PI(4,5)P2 
and PI3P, two phosphoinositides that function at the early stages of microbial phagocytosis and 
phagosome formation. this suggests that sapM may have a pleiotropic role with a wider importance 
on Mtb infection than initially thought. Finally, we have identified two inhibitors of SapM, L-ascorbic 
acid and 2-phospho-L-ascorbic, which define two different mechanisms by which the catalytic 
activity of this phosphatase could be regulated. Critically, we demonstrate that 2-phospho-L-ascorbic 
reduces mycobacterial survival in macrophage infections, hence confirming the potential of SapM as a 
therapeutic drug target.
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (Mtb), is one of the leading causes of 
death and poverty worldwide. The rise of multi-drug resistant (MDR), rifampicin resistant (RR), and extensively 
drug-resistant (XDR) TB poses major challenges in the treatment and eradication of this disease, which claims 
over 1.6 million lives every year (WHO TB Report 2017).
Mtb is an intracellular pathogen that prevents its clearance in the host by blocking critical phagosome mat-
uration events inside alveolar macrophages1–3. Subversion of phosphoinositide (PI) metabolism and dynamics 
is a key mechanism used by Mtb and other bacterial pathogens to arrest phagolysosome fusion thus preventing 
bacterial killing4,5. PIs are essential for the recruitment of effector proteins like EEA1 and the membrane remod-
elling ESCRT complexes, which drive the progression of early phagosomes to the degradative lysosomal pathway 
to eliminate the pathogen5. For Mtb infection, two secreted phosphatases have been implicated in subverting PI 
metabolism in the host to promote intracellular survival, MptpB6–8 and SapM9,10.
SapM, was initially described as a nonspecific acid phosphatase11, and later reported to dephosphorylate PI3P9 
a central player in phagosomal maturation12,13. Studies involving sapM deficient Mtb mutants supported a role for 
this protein in phagosome maturation arrest10,14 by preventing Rab5-Rab7 exchange15. In addition, SapM appears 
to have a role in immunogenicity14,16,17 and autophagy inhibition18. Notably, deletion of the sapM gene attenuated 
Mtb intracellular growth in human and mouse macrophages10,14 and reduced the mycobacterial burden in guinea 
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pig models of infection10. However, deletion of sapM did not affect mycobacterial growth in extracellular cul-
tures10 thus confirming its role as a virulence factor important for intracellular mycobacterial survival.
The growing evidence on the importance of SapM in pathogenesis makes it an attractive drug target for TB 
therapy, particularly since antivirulence drugs are gathering momentum as new therapeutic approaches to fight 
antimicrobial resistance8,19–21. However, the molecular mechanism of catalysis and mode of action of SapM is still 
largely unknown. This knowledge is crucial to fully exploit its potential as a pharmacological target, and to guide 
the design of specific inhibitors for drug development. To date a full biochemical and kinetics characterisation 
of this phosphatase has not been possible due to challenges in producing recombinant SapM. We have now suc-
cessfully expressed SapM in E. coli and purified it to homogeneity for enzymatic profiling and inhibition studies. 
The enzyme kinetics analysis and mutagenesis of conserved residues, indicates that SapM follows a serine-based 
mechanism of catalysis similar to alkaline phosphatases. The substrate specificity and inhibition profiles for SapM 
show differences with classical alkaline phosphatases indicating that SapM is an atypical member of this family.
In addition, we provide evidence of SapM activity towards a wide range of PIs with preference for PI(4,5)P2 
and PI3P. This suggests a potential new role for this phosphatase in pathogenesis by acting at the early stages of 
phagocytosis as well as in phagosomal maturation. Finally, we report that 2-phospho-L-ascorbic acid (2P-AC) is a 
competitive inhibitor of SapM and that reduces intracellular survival of Mtb in infected macrophages. This is the 
first evidence that inhibition of SapM could be exploited to control Mtb infection and underlines the potential for 
anti-virulence approaches to develop new therapies to treat TB.
Results
sapM shares conserved functional residues with acid and alkaline phosphatases. Bioinformatics 
approaches were used to analyse the sequence of SapM and related proteins. A BLAST search revealed ortho-
logues of SapM in all mycobacterial species with 70–99% pairwise identity (Fig. 1A). SapM-related sequences 
were also found in other bacterial and fungal organisms, although with lower identity (30–50%). Most of these 
proteins are currently annotated either as hypothetical proteins, uncharacterised or acid phosphatases, but their 
catalytic mechanism is unknown. These searches did not identify related sequences in higher eukaryotes.
InterPro analysis showed that SapM possesses a signature match to the phosphoesterase domain that is present 
in the superfamily of alkaline phosphatases22,23 and in the superfamily of acid phosphatases and phospholipases C 
(PLC/phosphatase superfamily)24.A prototype of classic alkaline phosphatases (AlkPs) is the Escherichia coli alka-
line phosphatase (Ec-AlkP)25, which shares 23% sequence similarity (16% identity) to SapM (Fig. 1A). Likewise, a 
well-characterised member of the PLC/phosphatase superfamily, the Francisella tularensis AcpA (Ft-AcpA), with a 3D 
structure similar to alkaline phosphatases26, shares 25% sequence similarity (15% identity) to SapM.
The low pairwise identity values made difficult a direct assignment of this enzyme to any of these families, 
but a multiple sequence alignment with representatives across the different superfamilies and the SapM-related 
sequences (Fig. 1A) highlighted the conservation within the phosphoesterase domain, of residues essential for 
catalysis and substrate binding in Ft-AcpA26,27, and Ec-AlkP25. This conservation includes the nucleophile serine 
(S175 in Ft-AcpA and S102 in Ec-AlkP), metal binding and substrate binding residues (Fig. 1A). Thus, the anal-
ysis suggested that SapM may share a similar serine-based, potentially metal-dependent, mechanism of catalysis 
Figure 1. Sequence alignment and domain architecture of SapM. (A) Multiple sequence alignment showing the 
active site region of SapM orthologues and related sequences. Alignment is shaded blue according to sequence 
conservation (conservation is also given by numbers from 1 to 10, with 10 (*) being 100% conservation). 
Numbers above the alignment correspond to SapM residue numbering. The catalytic residues are denoted 
on red background with white letters. Gene names are included alongside with microbial pathogen names. 
Alignment was performed using Clustal Omega58 and figure with Jalview Version 2.10.3b159. Two asterisks 
denote pairwise identity. Black dots denote the catalytic motif in both SapM orthologues (PSE) and alkaline 
phosphatase (DSA). (B) Domain architecture of SapM with boundaries for the mature protein annotated.
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with these enzymes, despite the modest overall conservation. To elucidate the catalytic mechanism of SapM, we 
carried out a comprehensive biochemical and kinetic characterisation of the enzyme.
the optimal enzymatic activity for sapM is at a basic pH. The SapM mature secreted native pro-
tein comprises residues 44 to 29911, which contains the whole phosphoesterase domain (Fig. 1B). A construct 
with a His-tagged version of the mature sequence was expressed in E. coli C41 (DE3), taking advantage of the 
periplasmic localisation sequence provided by the pET22b vector (Novagen). Soluble SapM was successfully 
obtained after treatment of the bacterial cell pellet with the ionic surfactant sarkosyl28 (see methods for details). 
Subsequently, purification by nickel-affinity chromatography produced 95% pure protein (Fig. 2A). SapM 
migrates according to the predicted molecular weight of 28.8 kDa for the mature protein plus the His6-tag (as 
calculated in ProtParam29). The identity of the purified protein was confirmed by tryptic digestion followed by 
LC/MS/MS analysis, and the intact mass calculated as 28,772.3 ± 0.19 Da. To the best of our knowledge, this is the 
first report of SapM being produced as a soluble recombinant protein following expression in E. coli.
Next, we evaluated the enzymatic activity of the purified SapM protein by measuring the conversion of 
p-Nitrophenyl phosphate (pNPP) into p-nitrophenol at different pH values and in the presence or absence of 
dithiothreitol (DTT). The optimal activity for SapM was obtained at pH 7.5 in the absence of DTT (Fig. 2B). We 
also confirmed the optimal activity at this pH for the protein after cleavage of the His-tag (Suppl. Fig. 1). This is in 
agreement with the enzyme activity pH range (6.5–7.5) reported for the native SapM11.
The addition of 3 mM DTT resulted in a considerable reduction of the specific activity at any pH, with a drop 
of activity of about 70% at pH 7.5 (Fig. 2B). Usually, DTT is used to prevent disulfide bond formation by reduc-
tion of Cys residues, which is particularly critical in Cys-based phosphatases where oxidation of the catalytic 
cysteine abolishes enzyme activity30. However, SapM protein lacks the hallmark active site P-loop motif (CX5R) 
present in Cys-based phosphatases31. Therefore, the effect of DTT potentially suggests a different mechanism 
in reducing enzyme activity. DTT can also act as a metal chelator due to its ability to form stable coordination 
complexes with metals32,33. Since the metal-binding residues identified in Ft-AcpA and Ec-AlkP are conserved in 
SapM, a potential explanation would be that the effect of DTT is due to chelation of a bound metal. Alternatively, 
DTT may impact on a metal oxidation state, which could similarly result in metal dissociation. These findings are 
therefore consistent with the suggestion that SapM is also a metal-dependent enzyme.
Mutagenesis of conserved residues suggests an alkaline-like mechanism of catalysis. Our bio-
informatics analysis showed that SapM shares conserved catalytic residues with Ec-AlkP and Ft-AcpA (Fig. 1A), 
both of which also follow an alkaline phosphatase mechanism of catalysis25,26. Ft-AcpA and Ec-AlkP both use a 
serine (S175 in Ft-AcpA and S102 in Ec-AlkP) as the nucleophile, which is activated by metal ions, three in the 
case of Ec-AlkP (two Zn2+ and Mg2+)25,34 and only one in the case of Ft-AcpA26. The crystal structure of Ft-AcpA 
in complex with vanadate26 revealed four histidines (H106, H287, H288 and H350) critical for substrate binding. 
In the Ft-AcpA structure the metal ion is coordinated by seven oxygen atoms from residues N44, E43, D386, 
D387 and the vanadate molecule (Fig. 3A). Key catalytic residues in Ft-AcpA are also present in the structure of 
Ec-AlkP25 (Fig. 3A). Based on the multiple sequence alignment, up to eight residues important in Ft-AcpA catal-
ysis and substrate binding are conserved in SapM (Figs 1A, 3A).
Figure 2. Expression, purification and enzymatic activity of SapM. (A) Coomassie stained 10% SDS-PAGE 
gel shows expression and purification of recombinant SapM (Mw 28.8 kDa) (lane E). Solubilisation was 
achieved using 1% sarkosyl in the lysis buffer. Purification was done by nickel-affinity chromatography and 
eluted with 200 mM imidazole. U: uninduced, I: induced, TCE: total cell extract, P: pellet, S: soluble, W: wash, 
and E: elution. (B) Enzymatic activity of SapM was assessed using the p-Nitrophenyl phosphate (pNPP) assay. 
Hydrolysis of pNPP was measured at pH values ranging from 4 to 9 in the presence and absence of 3 mM 
dithiothreitol (DTT). Specific activity (SA) was calculated as nanomoles of p-nitrophenol (pNP) released per 
mg of protein and min of the reaction. Error bars represent standard deviation of the mean (SD) of triplicates.
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We explored the role of these conserved residues in SapM, by mutagenesis and enzyme activity assays. The 
SapM mutants S95A, N60A, E59A, D238A, E239A, H160A and H204A exhibited no activity towards pNPP, even 
at longer incubation times of up to 90 min (Fig. 3B). Using the catalytic mechanism described for Ft-AcpA as a 
reference, we propose S95 to act as the nucleophile in SapM. Residues E59, N60, D238 and E239 align with the 
metal-binding site described for Ft-AcpA, and an analogous role in metal-binding is supported by their require-
ment for SapM-mediated catalysis. The residues H160 and H204 may be involved in substrate binding as their 
cognate residues H288 and H350 in Ft-AcpA. In fact, mutation of Ft-AcpA H288 and H350 to alanine, also 
resulted in lack of enzyme activity in that enzyme27.
Interestingly, the SapM K159A mutant showed only reduced activity towards pNPP with respect to the 
wild-type enzyme (Fig. 3B), indicating that it is important but not essential for catalysis. Analogous residues 
H287 in Ft-AcpA27 and R166 in Ec AlkP25, appear to have a role in substrate binding as well. Our mutagenesis 
studies thus confirmed the importance of the conserved residues S95, N60, E59, D238, E239, H160, H204 and 
K159 in SapM catalysis and substrate binding. These data and the proposed role for these residues indicate that 
SapM follows a serine-based alkaline-like mechanism of catalysis similar to that of Ec-AlkP and Ft-AcpA with 
S95 acting as the nucleophile.
Influence of metal ions in SapM enzymatic activity. In order to study the potential role of metal ions 
in SapM activity, we performed enzymatic assays in the presence of a range of transition (Co2+, Ni2+, Zn2+, Mn2+, 
Cu2+and Fe3+) and alkaline metals (Ca2+ and Mg2+). The activity of SapM was totally inhibited by zinc, and 
reduced by >50% in the presence of copper, cobalt and nickel. Magnesium was the only metal that did not affect 
the enzymatic activity of SapM (Fig. 4A). Next, using electron paramagnetic resonance (EPR) spectroscopy, we 
tested for the presence of Fe3+, Ni2+, Mn2+, Cu2+ and Co2+. No signal for any of these metal ions was detectable, 
indicating that none of these metals are bound to the enzyme under the conditions tested. We also carried out 
inductively coupled plasma mass spectrometry (ICP-MS) analysis of purified SapM, which failed to detect the 
presence of protein associated metals (Mg, Ca, Cr, Co, Ni, Cd, Cu, Zn or Fe). Thus, whilst none of these metals 
are co-purified with SapM, it remains possible that they can bind to SapM and inhibit activity by displacing an as 
yet unidentified metal-cofactor. It is noteworthy that these experiments were repeated with SapM purified with 
EDTA-free buffers (including lysis buffer), but the results were unchanged.
High concentrations of DTT (10 mM) completely inhibited SapM activity (Fig. 4B), supporting the idea that DTT 
may be acting (chelating or changing oxidation state) on an unknown metal that is resistant to high concentrations 
(10 mM) of the divalent chelators ethylenediaminetetraacetic acid (EDTA) and egtazic acid (EGTA) (Fig. 4B).
sapM is an atypical monoester alkaline phosphatase. Next, we tested a wide range of phospho-substrates 
to establish the specificity of SapM. SapM hydrolysed a wide range of different phospho-substrates and fifteen of 
them with a specific activiy of at least 50% with respect to pNPP (Fig. 5A), indicating a broad specificity. Kinetic 
analysis of the best substrates showed that SapM displays the highest efficiency (kcat/Km) towards the triphosphate 
nucleosides ATP and GTP (Fig. 5B). SapM also hydrolysed cysteamine S-phosphate, a substrate for classic alka-
line phosphatases35, with a specific activity of 57% with respect to pNPP hydrolisis (Fig. 5A).
Figure 3. Identification of catalytic residues in SapM. (A) Schematic diagram showing the active site residues of 
AcpA from F. tularensis (Ft-AcpA in black). Conserved residues in SapM (in blue) and in the alkaline phosphatase 
from E. coli (Ec-AlkP in red) are shown. The metal ion has an octahedral coordination made of oxygens in AcpA 
and the vanadate that occupies the substrate-binding site26. The underlined residues from Ec-AlkP occupy similar 
structural location with Ft-AcpA. SapM residues involved in metal binding (underlined in orange) and substrate 
binding (underlined in green) are highlighted. (B) Specific Activity (SA) of wild-type and mutants of the conserved 
residues in SapM measured by pNPP assay. Mutant K159A shows reduced activity with respect to the wild-type 
whereas the other mutations completely abolish the enzymatic activity of SapM (values overlap along the X-axis). 
Specific activity was calculated as nanomoles of p-nitrophenol (pNP) released per mg of protein and min of the 
reaction. Error bars indicate standard error of the mean (SEM) of two independent experiments.
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The activity of SapM towards the phosphodiester substrates bis-p-nitrophenyl phosphate (Bis pNPP) and 
adenosine 3′,5′-cyclic monophosphate (c-AMP), typical substrates of phosphodiesterases36,37, was less than 5% 
with respect to pNPP hydrolisis. SapM therefore shows a clear preference for phosphomonoesters over phos-
phodiester substrates, ruling out that it functions as a phosphodiesterase.
Figure 4. Effect of metals and inhibitors on the enzymatic activity of SapM. Enzymatic activity of SapM was 
assessed using the pNPP assay. (A) SapM activity is tested in the presence of various metals (10 mM, except 
for FeCl3 that was used at 1 mM). (B) SapM activity was tested in the presence of 10 mM of metal chelators 
ethylenediaminetetraacetic acid (EDTA) egtazic acid (EGTA) and inhibitory compounds: orthovanadate (Na-
OV) and sodium molybdate (Na-Mb), tetramisole hydrochloride (THC), sodium tartrate (Na-Tr), sodium 
fluoride (NaF) and dithiothreitol (DTT). Percentage of specific activity is calculated relative to the amount of 
p-nitrophenol released from the hydrolysis of pNPP of the control (without metals or inhibitors). Error bars in 
A and B indicate SEM of two independent experiments.
Figure 5. Substrate specificity profile for SapM. Enzymatic activity of SapM protein was assessed using the 
malachite green assay. (A) SapM was tested for hydrolysis of phosphosubstrates at 80 µM. Percentage of specific 
activity is calculated relative to the amount of inorganic phosphate (Pi) released from the hydrolysis of pNPP 
substrate. Arrow highlights a substrate specific for alkaline phosphatases (AlkP). Error bars indicate SEM of 
three independent experiments. (B) Kinetic parameters for SapM dephosphorylation of substrates with specific 
activity >50% with respect to pNPP substrate. Values indicate SEM of two independent experiments. ATP 
(adenine triphosphate), G6P (glucose 6-phosphate), GTP (guanosine triphosphate), P-Tyr (phosphotyrosine), 
ADP (adenosine diphosphate), PEP (phosphoenolpyruvate), α-NP (α-Naphthyl phosphate), 2P-AC (2-phospho 
ascorbic acid), AMP (adenosine monophosphate), F1,6bP (fructose 1,6-bisphosphate), NADPH (nicotinamide 
adenine dinucleotide 2′-phosphate reduced), P-Ser (phosphoserine), CysS-P (cysteamine S-phosphate), FMN, 
(riboflavin monophosphate), F6P (fructose 6-phosphate), GMP (guanosine monophosphate), IMP (inosine 
monophosphate), GlyP (glycerophosphate), PEth (O-phosphorylethanolamine), T6P (threalose 6-phosphate), 
PhyA (phytic acid), P-Thr (phosphothreonine), PC (Phosphorylcholine chloride), Bis pNPP (bis p-nitrophenyl 
phosphate), c-AMP (adenosine 3′,5′-cyclic monophosphate).
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Next we tested common inhibitors of protein phosphatases. The oxyanions, vanadate and molybdate, which 
are inhibitors of classic phosphotyrosine phosphatases (PTPs)38, abolished SapM activity (Fig. 4B). High concen-
trations (10 mM) of tetramisole hydrochloride, an alkaline phosphatase inhibitor35, did not inhibit the enzyme 
activity. Likewise, SapM activity was resistant to sodium fluoride (acid phosphatase inhibitor) and sodium tartrate 
(acid phosphatase and Ser/Thr phosphatase inhibitor) (Fig. 4B). These findings suggest a mixed type of inhibition 
profile for SapM matching neither classic acid phosphatases, nor alkaline phosphatases.
The broad substrate specificity of SapM, together with the optimal pH of 7.5 is similar to that observed in the 
alkaline phosphatase family. However, SapM shares only 16% identity with the closest classical alkaline phos-
phatase, Ec-AlkP, and lacks the characteristic catalytic motif present in alkaline phosphatases, DSA (D101, S102 
and A103 in Ec-AlkP), where S is the nucleophile residue25. Instead, SapM has a PSE motif, conserved in all myco-
bacterium orthologues and microbial related sequences (Fig. 1A), which contains the catalytic S95.
Previous studies suggested that SapM could be a nonspecific acid phosphatase (NSAP) or a His-based phos-
phatase11. Our analyses indicate that SapM does not contain the characteristic motifs found in His-based phos-
phatases, such as the catalytic RHGXRXP motif39, where the histidine is the nucleophile. SapM is also missing the 
conserved active site motif CX5R of acid phosphatases31, and does not present any of the characteristic motifs of 
NSAP described up to now40. These data, together with the identification of the catalytic residues, indicate that 
SapM behaves as an atypical alkaline phosphatase with broad monoesterase activity.
SapM shows specificity for PI(4,5)P2 and PI3P. Previous studies9 suggested that the native SapM was 
able to dephosphorylate mono-phosphorylated phosphoinositides (PIs), specifically PI3P. However, nothing 
was reported about SapM activity towards the di and tri-phosphorylated PIs. Surprisingly, the isolated SapM 
can hydrolyse a wide range of phosphoinositides (Fig. 6A), but preferentially dephosphorylates PI(4,5)P2 and 
PI3P, showing higher kcat/Km values over the rest. In contrast, SapM shows 5 to 10 times lower catalytic effi-
ciency towards the mono-phosphorylated PI4P and PI5P due to a much lower affinity (Km) for these compounds 
(Fig. 6B).
Interestingly, the K159A mutant showed less than 2% activity towards PI(4,5)P2, and PI3P whilst retaining 
21% and 13% activity for pNPP and ATP, respectively (Fig. 6C). Kinetic analyses also revealed a 2-fold increase 
in Km and a 10-fold decrease in kcat/Km for K159A towards ATP (Fig. 6D), confirming its role in substrate binding 
as proposed for its analogues H287 in Ft-AcpA27 and R166 in Ec-AlkP41. Hence, similarly to R166 in Ec-AlkP25, 
K159 may provide additional stabilisation of the negatively charged phosphosubstrates, which is clearly critical 
for hydrolysis of phosphoinositides that contain extra negatively charged phosphate groups.
The specificity of SapM for PI(4,5)P2 in addition to PI3P is intriguing and suggests that this phosphatase may 
have more than one role in infection and pathogenesis, since these PIs localise to the plasma/phagocytic mem-
brane and early phagosome membrane, respectively.
Inhibition of sapM enzymatic activity. Inhibition studies indicated that L-ascorbic acid (L-AC) and 
2-phospho-L-ascorbic acid (2P-AC) inhibit the enzymatic activity of Ft-AcpA27. Since SapM shares a similar 
mechanism of catalysis with Ft-AcpA, we speculated that these compounds may also inhibit SapM. An initial 
test showed that 10 mM of L-AC and 2P-AC completely abolished the enzyme activity of SapM. Subsequently 
we determined the IC50 to be 241 µM for L-AC and 234 µM for 2P-AC (Fig. 7A,B). The mechanism of inhibition 
by these compounds differs. L-AC acts as uncompetitive inhibitor as noted by variations of the Vmax and the 
Km at different inhibitor concentrations (Fig. 7C). L-AC is a potent oxidant and thus its inhibition may be the 
result of metal oxidation in the enzyme-pNPP complex42, explaining the uncompetitive mechanism of inhibition 
observed. In contrast, 2P-AC behaves as a competitive inhibitor, since variations in its concentration produced 
marked changes in the Km while the Vmax remained unchanged (Fig. 7D). Since SapM can also hydrolyse 2P-AC 
(Fig. 5), this compound may inhibit SapM activity in a two-way mechanism: by competing with pNPP for binding 
to the active site, and as a metal oxidant, as a result of its ascorbic acid production due to hydrolysis.
2-phospho-L-ascorbic acid reduces survival of M. tuberculosis in infected macrophages, 
although does not affect extracellular growth. Next, we evaluated the effect of these SapM inhibitors 
on Mtb extracellular growth. For this, growth of the Mtb H37Rv strain was monitored over the course of 11 days 
(Fig. 8A) with and without the addition of the inhibitors. Cultures were treated with different concentrations of 
L-AC and 2P-AC added in day 0 and 1, and growth was monitored using optical density (OD600). Mycobacterial 
growth was severely reduced from day 2 with 4 mM L-AC, and even a lower concentration (1 mM) L-AC had 
a significant (p = 0.0039) effect in growth reduction (Fig. 8A). These findings are in agreement with previous 
studies showing the effect of L-AC on mycobacterial growth43. In contrast, treatment with 1 mM 2P-AC did not 
affect mycobacterial growth (Fig. 8A), while treatment with 4 mM 2P-AC showed only significant reduction of 
mycobacterial growth from day 7 (p = 0.0048). The delayed effect of 2P-AC may be due to slow spontaneous 
hydrolysis in solution of the phosphate group to generate ascorbic acid, as previously reported44, plus hydrolysis 
by the secreted SapM. Thus, while L-AC shows a severe effect on inhibiting Mtb extracellular growth, the presence 
of the phosphate group in 2P-AC appears to have a protective effect, during the first 7 days post-treatment.
Previous studies have demonstrated that deletion of the sapM gene, results in reduction of mycobacterial bur-
den within macrophages and guinea pig models of infection10,14,15. We hypothesised that chemical inhibition of 
SapM may recapitulate the effect of the sapM knockout, thus reducing intracellular mycobacterial survival. To test 
this, we assessed the efficacy of 2P-AC in reducing Mtb (H37Rv) survival in resting human THP1 macrophages. 
We observed a significant (p = 0.0365) reduction in bacterial burden at 72 h post-infection of 39% upon treat-
ment with 4 mM 2P-AC compared to the non-treated control (Fig. 8B). Control experiments showed that 2P-AC 
has no detrimental effect on macrophage viability (Fig. 8B inset). In addition, inhibition of 2P-AC is specific for 
SapM, as it did not inhibit the other secreted mycobacterial phosphatases MptpA and MptpB when tested at 
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4 mM concentration. Importantly, 2P-AC showed no effect on extracellular cultures of Mtb at 72 h, therefore the 
reduction in bacterial burden observed is consistent with the proposed role of SapM in mycobacterial intracel-
lular survival10,14. These findings demonstrate that SapM inhibition may be effective in assisting mycobacterial 
clearance during infection, thus providing a novel mechanism of action for TB treatment.
Discussion
In this study, we provide new insights into the mechanism of catalysis, substrate specificity and inhibition of 
SapM. Our findings demonstrate that SapM is an atypical monoester alkaline phosphatase, with a serine-based 
mechanism of catalysis probably metal-dependent. Particularly relevant to SapM function and pathogenesis, is its 
activity towards PI(4,5)P2 and PI3P, two PIs that act at the early stages of microbial phagocytosis and phagosome 
formation. This suggests that SapM may have a pleiotropic role with a much wider impact on Mtb infection than 
initially thought. Finally, we have identified two inhibitors of SapM, 2P-AC and L-AC, which define two different 
mechanisms (competitive and metal oxidation) by which the catalytic activity of this phosphatase could be regu-
lated. Critically we demonstrate that 2P-AC reduces mycobacterial survival in macrophage infections.
Our bioinformatics analysis revealed that SapM and orthologues share a conserved phosphoesterase domain 
with the superfamily of alkaline phosphatases (Fig. 1A). Consistent with this, we have demonstrated that SapM 
is a monoester phosphatase capable of hydrolysing a broad range of phosphosubstrates including cysteamine 
S-phosphate, an alkaline phosphatase substrate, and ATP for which the enzyme showed the highest specific-
ity (Fig. 5A,B). Based on the multiple sequence alignment and using mutagenesis and activity assays, we have 
Figure 6. SapM hydrolyses phosphoinositides (PIs). Enzymatic activity of SapM protein was assessed using 
the malachite green assay. (A) SapM activity was tested on seven phosphoinositides at 80 µM. Percentage 
of specific activity is calculated relative to the amount of inorganic phosphate (Pi) released from the 
hydrolysis of pNPP substrate. (B) Kinetic parameters for SapM dephosphorylation of phosphoinositides. 
PI(3,4)P2 (phosphoinositide 3,4 di-phosphate), PI(3,4,5)P3 (phosphoinositide 3,4,5 tri-phosphate), PI(4,5)P2 
(phosphoinositide 4,5 di-phosphate), PI(3,5)P2 (phosphoinositide 3,5 di-phosphate), PI3P (phosphoinositide 
3 phosphate), PI4P (phosphoinositide 4 phosphate), PI5P (phosphoinositide 5 phosphate). (C) The enzymatic 
activity of K159A mutant was tested on pNPP, ATP, PI(4,5)P2 and PI3P at 80 µM. Specific activity was calculated 
as nanomoles of inorganic phosphate released per mg of protein and min of the reaction. (D) Kinetic analysis of 
the K159A towards ATP respect to the wild-type enzyme. Values and error bars in A, B, C and D indicate SEM 
of two independent experiments.
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identified for the first time the key catalytic residues of SapM, including the nucleophile S95 and residues (E59, 
N60, D238 and E239 H160 and H204) which are associated with metal and substrate binding (Fig. 3A,B). 
Furthermore, we have identified Lys159, as critical for phosphoinositide binding (Fig. 6C,D).
SapM shares a similar mechanism of catalysis with another phosphatase, Ft-AcpA, which is critical for sur-
vival of F. tularensis in host cells. Inhibition of Ft-AcpA with 2P-AC impaired survival of F. tularensis in infected 
macrophages27. We have demonstrated in this study, that 2P-AC is a competitive inhibitor of SapM (Fig. 7D) with 
efficacy in reducing mycobacterial burden in infected macrophages, despite having no effect on extracellular 
bacterial cultures (Fig. 8A,B). We expect that more potent inhibitors, perhaps based on the 2P-AC scaffold, would 
provide good starting points for drug development and further validation of SapM as a drug target.
Figure 7. Mechanism of inhibition of SapM activity by L-ascorbic acid and 2-phospho-L-ascorbic acid. 
Inhibition curves for L-ascorbic acid (L-AC) (A) and 2-phospho-L-ascorbic acid (2P-AC) (B) using the pNPP 
assay. Percentage of specific activity is calculated relative to the amount of p-nitrophenol released in the absence 
of inhibitor. Lineweaver-Burk plots of SapM activity towards pNPP at increasing concentrations of L-AC (C) 
and 2P-AC (D). L-AC behaves as uncompetitive inhibitor as noted by variations of the Vmax and the Km at 
different inhibitor concentrations, whereas 2P-AC behaves as a competitive inhibitor as observed by changes 
of the Km while the Vmax remained unchanged at different inhibitor concentrations. Error bars in A, B, C and D 
represent SD of triplicates.
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Manipulation of the host phosphoinositide metabolism is a common mechanism in microbial pathogenesis 
to promote colonisation of macrophages during infection4,5,45,46. This is particularly relevant for Mtb infections 
where alteration in PI dynamics affects phagosomal maturation and enables long-term survival of the bacteria 
in alveolar macrophages. We show in this study that SapM is able to hydrolyse all seven phosphoinositides albeit 
with higher specificity for PI(4,5)P2 and PI3P, and to our knowledge, SapM is the first bacterial phosphatase to 
show such a broad PI activity.
Previously, another two secreted phosphatases, MptpA and MptpB, have been implicated in the regulation of 
phagosomal maturation by Mtb8,47–49. Based on the current knowledge and our new data on the activity of SapM, 
we propose a model in which these three mycobacterial phosphatases MptpA, MptpB and SapM, could be acting 
in a coordinated manner to control phagosome biogenesis, acidification and maturation, blocking phagolyso-
some fusion and thus promoting survival of Mtb in the macrophage (Fig. 9).
The role of Mtb in phagosome maturation arrest is a complex mechanism where many players take part at dif-
ferent stages5 (Fig. 9). Initial phagosome formation and scission from the plasma membrane requires hydrolysis 
of PI(4,5)P250. This is a critical step for pathogenic invasion as described for Salmonella51 and Yersinia52. In this 
context, PI(4,5)P2 hydrolysis by SapM could represent a critical step to facilitate Mtb uptake and colonisation of 
the host.
The early phagosome membrane is characterised by the presence of PI3P critical for phagosomal maturation 
downstream events5,9. Hydrolysis of PI3P by SapM has been implicated in phagosome maturation arrest9. We 
have previously reported that MptpB, also dephosphorylates PI3P49, and that inhibition of MptpB, affects PI3P 
dynamics in infected macrophages8. Hence, it is probable that the combined hydrolysis of PI3P by both SapM and 
MptpB enhances maturation arrest at this early stage. MptpB also dephosphorylates PI(3,5)P249, a key lipid for late 
phagosome formation and fusion to lysosomes53.
Another critical event that promotes Mtb survival is the prevention of phagosome acidification. Acidification 
is triggered by V-ATPase (proton-pumping ATPase) recruitment, which requires ATP to translocate protons 
(H+) creating the acidic environment inside the phagosome54. MptpA inhibits V-ATPase trafficking to the myco-
bacterial phagosome by dephosphorylation of VPS33B (human vacuolar protein sorting 33B)47, thus preventing 
acidification. Since SapM hydrolyses ATP with high efficiency, this could also contribute to prevent acidification. 
Therefore, arrest of phagolysosomal fusion and subsequent bacterial destruction may be controlled by the coordi-
nated activities of these three secreted phosphatases to enhance mycobacterial survival in the host (Fig. 9). Testing 
this model and the spatio-temporal involvement of three Mtb phosphatases in phagosome maturation and PI 
dynamics will be the focus of future work.
Material and Methods
Bioinformatics analysis. BLAST searches in the UniProt Knowledgebase (UniProtKB)55, were performed 
using the full length sequence to identify SapM-related sequences. Next, using InterPro database56 conserved 
domains and families were identified57. For the BLAST searches, the E-Threshold was set at two values: 0.0001 
and 10. Multiple sequence alignments were performed using Clustal Omega58 and manually edited using the 
program Jalview Version 2.10.3b159.
Figure 8. Effect of L-AC and 2P-AC on Mycobacterium tuberculosis H37Rv growth. (A) The inhibitory effect 
of L-AC and 2P-AC on the extracellular growth of M. tuberculosis (Mtb) H37Rv was monitored by measuring 
optical density (OD600) over time. Cultures were treated with 1 mM or 4 mM of the inhibitors at day 0 and 1 
and grown over 11 days. Statistical significance was evaluated by two-way ANOVA (Bonferroni test) where 
**p = 0.0039; **p = 0.0048; **p = 0.0059; ***p = 0.0010 and ****p < 0.0001. Control is without inhibitor. 
(B) Effect of 2P-AC on intracellular Mtb survival in human THP1 macrophages. Significant reduction of 
mycobacterial growth (*p = 0.0365 by one-way ANOVA, Bonferroni test) is observed at 4 mM compared to 
the control (without inhibitor). Plots represent the average of CFU/ml at 72 h post infection. Inset shows THP1 
viability at 72 h upon treatment with 2P-AC. Error bars in A and B indicate SEM of two independent experiments.
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Cloning and mutagenesis of sapM. The open reading frame of Rv3310, encoding the SapM gene, was 
amplified from Mycobacterium tuberculosis (Mtb) H37Rv DNA. The amplicon from residues 44 to 299, 
corresponding to the mature protein11 was cloned into pET22b (Novagen) vector using the forward (5′-GCTGCTCCAT 
GGCGAGTGCCCTGCCGACC-3′) and reverse (5′- GCTCGTGCGGCCGCGTCGCCCCAAATATCG 
GTTATTGG-3′) primers containing NcoI and NotI restriction sites (New England Biolabs, UK) to generate the 
C-terminal His6-tagged SapM construct. Site directed mutagenesis was carried out using AccuzymeTM DNA 
Polymerase (BIOLINE) for thermal cycling and the PCR product inserted into pET22b vector. The His6-tagged 
SapM construct was used as a template. DNA sequence analyses confirmed that residues E59A, N60A, S95A, 
K159A, H160A, H204A, D238A and E239A were mutated and that no additional changes were introduced.
Overexpression and purification of recombinant SapM. Constructs (wild-type and mutants) were 
transformed into Escherichia coli C41 (DE3) strain for expression of recombinant proteins. Single colonies of 
E. coli C41 (DE3) were inoculated in 10 ml of LB (Luria-Bertani) broth supplemented with ampicillin (100 µg/ml) 
and 1% glucose and incubated overnight. Subsequently the overnight culture was diluted into 400 ml of 
auto-induction media60 and grown at 37 °C with shaking (220 rpm) until OD600 reached ~0.4. The culture temper-
ature was reduced at 20 °C for protein expression and culture was harvested (6500 g for 15 min at 4 °C) 24 h later. 
Recombinant SapM (wild-type and mutants) was purified by nickel-affinity chromatography using an AKTA 
purification system (GE Healthcare). Cell pellets were re-suspended in lysis buffer containing 50 mM HEPES, 
500 mM NaCl, with 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mg/ml lysozyme, 1% N-lauroylsarcosine 
sodium salt (sarkosyl) (Sigma-Aldrich), 38 units/ml of benzonase nuclease (Sigma-Aldrich) and complete 
EDTA-free protease inhibitor cocktail (Roche), pH 7 and incubated on ice for 30 min. Cells were disrupted by 
sonication (Sonics Vibra-Cell). Lysates were cleared by centrifugation at 12,000 g for 1 h at 4 °C. The cell lysate 
was filtered through a 0.45 µm flask filter and loaded onto a 1 ml HisTrapTM HP column (GE Healthcare) in 
binding buffer containing 50 mM HEPES, 500 mM NaCl and 0.05% sarkosyl, pH 7 and washed with buffer con-
taining 50 mM HEPES, 500 mM NaCl and 0.05% Sarkosyl, and 60 mM imidazole, pH 7. Protein was eluted with 
a gradient of imidazole (from 60 mM to 250 mM) in the elution buffer. Fractions containing the protein were 
further purified using a second 1 ml HisTrapTM HP column and eluted with 200 mM imidazole in elution buffer 
(50 mM HEPES, 500 mM NaCl and 0.05% Sarkosyl). Purity of fractions was verified in a coomassie-stained 10% 
SDS-PAGE run under reducing conditions with beta-mercaptoethanol. The identity of SapM was confirmed by 
trypsin digestion and mass spectrometry (LC/MS/MS) using a sample protein excised from an acrylamide gel 
corresponding to the second IMAC purification. Multiangle light scattering analysis confirmed a molecular mass 
of 30.3 kDa and that the sample was monodisperse after IMAC purification.
Figure 9. M. tuberculosis secreted phosphatases regulate phagocytosis and phagosome maturation. After 
target recognition pseudopodia extension is triggered by an increment of PI(4,5)P2 in the plasma membrane 
together with actin polymerization. Sealing of the phagosome is characterised by actin depolymerization and 
loss of PI(4,5)P2. SapM may accelerate actin depolymerization by hydrolysing PI(4,5)P2 to ensure Mtb uptake 
by the host. The early phagosome is characterised by the presence of Rab5, PI3P and EEA1, essential molecules 
to allow early phagosome-endosome fusion. Hydrolysis of PI3P by SapM and MptpB prevents the Rab5-Rab7 
exchange that mediates the transition to late phagosome. Phagosomal acidification occurs by acquisition of 
V-ATPase that uses ATP. SapM may contribute in preventing acidification by hydrolysis of ATP. MptpA inhibits 
phagosome acidification by hydrolysis of VPS33B and inhibition of V-ATPase trafficking to the late phagosome. 
MptpB hydrolyses PI(3,5)P2, which is required for late phagosome/phagolysosome fusion. The coordinated 
action of the three secreted phosphatases prevents phagolysosome fusion and pathogen destruction thus 
promoting Mtb survival in the host.
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overexpression and purification of MptpA and MptpB. The N-terminal histidine tagged con-
structs for MptpA and MptpB were generated as previously described7,8. Constructs were transformed into E. 
coli BL21(DE3) and expression induced at 18 °C with 0.5 mM IPTG (isopropyl-β-D-thiolgalactopyranoside) 
for MptpB and 0.1 mM IPTG for MptpA for 16 h. Purification of both MptpA and MptpB was done by nickel 
affinity chromatography followed by a size exclusion chromatography using a Superdex75 (10/300) column (GE 
Healthcare). MptpB and MptpA proteins were eluted in buffer containing 20 mM Tris-Base, 150 mM NaCl, 3 mM 
EDTA, pH 7.
Activity assays using p-Nitrophenyl phosphate (pNpp). Enzymatic activity of SapM was assessed by 
hydrolysis of p-nitrophenyl phosphate (pNPP) (Sigma-Aldrich) according to the manufacturer’s protocol. Briefly, 
we tested pH ranges 4 to 6, using a 150 µl reaction mixture containing 0.5 µg protein, 1 mM pNPP in 50 mM 
Tris-Base, 150 mM sodium acetate with/without 3 mM dithiothreitol (DTT) and pH ranges 7 to 9.5 in 50 mM 
Tris-Base, 150 mM NaCl and with/without 3 mM DTT. Samples were incubated at 37 °C for 30 min at which time 
the reaction was quenched by adding 50 µl of NaOH 1 M. The absorbance was subsequently read at 405 nm using 
a Multiskan® Spectrum spectrophotometer (Thermo Scientific). The concentration of p-nitrophenol produced 
was determined using a p-nitrophenol standard curve (15 µM–2000 µM of Sigma-Aldrich p-nitrophenol standard 
solution). Optimal pH was tested using the His6-tagged and naked SapM protein (without the tag). The assay was 
optimized with respect to time and protein concentration so that the reaction is performed within the linear range 
of the initial velocity.
The effect of metals and inhibitory compounds were tested using a 150 µl reaction mixture containing 1 µg 
of protein in 50 mM Tris-Base, 150 mM NaCl, pH 7.5 and the different metals or inhibitory compounds (metals 
and inhibitory compounds at 10 mM, except FeCl3 at 1 mM) and incubated for 30 min at room temperature, 
followed by the addition of pNPP to a final concentration of 500 µM and further incubated for 30 min at 37 °C. 
The reaction was quenched by adding 50 µl of NaOH 1 M followed by the steps explained above. Metals and 
compounds sodium tartrate (Na-Tr), egtazic acid (EGTA), sodium fluoride (NaF), 2-phospho-L-ascorbic acid 
(2P-AC), sodium orthovanadate (Na-OV), sodium molybdate (Na-Mb), L-ascorbic acid (L-AC) were all from 
Sigma-Aldrich. EDTA, (Fisher Scientific) and tetramisole hydrochloride (THC) (Fluorochem).
The phosphatase activity of SapM (wild-type and mutants) was determined using a 150 µl reaction mixture 
containing 0.5 µg of protein and 1 mM pNPP in 50 mM Tris-Base, 150 mM NaCl, pH 7.5 and incubated at 37 °C 
for 30 min, 60 min and 90 min. The absorbance was read at 405 nm every 30 min after quenching the reaction. 
Concentration was calculated as explained above. All the experiments were performed in triplicates in 96-well 
microplates F-bottom clear plates (Greiner bio-one) in at least two separate studies.
Activity assays using the Malachite Green Assay. The amount of free phosphate during the dephos-
phorylation of phosphosubstrates was determined with the malachite green assay (Sigma-Aldrich) according to 
the manufacturer’s protocol. The substrates tested were: phosphoinositide substrates diC8-PI3P, diC8-PI(3,4)P2, 
diC8-PI(3,5)P2, diC8-PI4P, diC8-PI(4,5)P2, diC8-PI5P, and diC8-PI(3,4,5)P3 (all from Echelon Bioscience), 
O-phospho-L-tyrosine (P-Tyr), O-phospho-L-serine (P-Ser), O-phospho-L-threonine (P-Thr), cysteamine 
S-phosphate sodium salt (CysS-P), bis-(p-nitrophenyl) phosphate sodium salt (Bis pNPP), phosphorylcholine 
chloride (PC), O-phosphorylethanolamine (PETh), mono-sodium phosphoenolpyruvate hydrate (PEP), glyc-
erophosphate disodium salt hydrate (GlyP), inosine 5′-monophosphate disodium salt hydrate (IMP), guano-
sine 5′-monophosphate disodium salt hydrate (GMP), guanosine 5′-triphosphate sodium salt hydrate (GTP), 
adenosine 5′-triphosphate (ATP) disodium salt hydrate, adenosine 5′-diphosphate sodium salt (ADP), adenosine 
5′-monophosphate disodium salt (AMP), trehalose 6-phosphate dipotassium salt (T6P), D-fructose 6-phosphate 
disodium salt hydrate (F6P), phytic acid (PhyA), α-naphthyl phosphate (α-NP), β-nicotinamide adenine 
dinucleotide 2′-phosphate reduced tetrasodium salt hydrate (NADPH), riboflavin 5′-monophosphate sodium 
salt hydrate (FMN), adenosine 3′,5′-cyclic monophosphate sodium salt monohydrate (c-AMP), D-glucose 
6-phosphate sodium salt (G6P) (all from Sigma-Aldrich), and adenosine 5′-monophosphate sodium salt (AMP) 
(Fisher Scientific).
The specific activity of SapM towards the 34 substrates was determined using a 100 µl reaction mixture con-
taining reaction buffer (50 mM Tris-Base, 150 mM NaCl, pH 7.5), 80 µM of substrate and 1 µg of protein. The 
reaction mixtures were incubated at 37 °C for 30 min prior to the addition of 15 µl of malachite green reagent. 
Subsequently, the reaction was further incubated for 15 min at room temperature (21 °C). The absorbance was 
read at 620 nm using a Multiskan® Spectrum spectrophotometer (Thermo Scientific). The concentration of free 
phosphate produced was determined using a phosphate standard curve (25–3000 pmol of Sigma-Aldrich phos-
phate standard solution).
Specificity activity (wild-type and mutants) towards pNPP, ATP, PI3P and PI(4,5)P2 was evaluated with 80 µM of 
substrate and 0.1 µg of protein. For kinetic measurements (wild-type and mutants), we used 3–750 µM of substrate and 
0.1 µg of protein. Incubation was at 37 °C for 1 h. Following steps were the same as explained above. All the experiments 
were performed in triplicates in 96-well microplates F-bottom clear plates in at least two separate studies.
Kinetic analysis. The Michaelis-Menten kinetic parameters Vmax and Km were calculated using non-linear 
regression fit in GraphPad Prism 7.01 for Windows by plotting velocity as a function of pNPP concentration. The 
kcat was determined by dividing the Vmax by the molar enzyme concentration. Values are calculated as average of 
at least two separate studies performed in triplicates with ±SEM.
epR and ICp-Ms studies. Both analyses were performed using a sample containing ~4 mg/ml of protein 
in 200 mM NaCl, 20 mM HEPES, pH 7 with and without EDTA present. For EPR, continuous‐wave EPR spectra 
were recorded at 9.4 GHz (X‐band) on a Bruker EMX spectrometer equipped with a Super‐high‐Q rectangular 
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cavity and an Oxford ESR‐900 liquid helium cryostat. Instrument operating conditions were modulation ampli-
tude 4.0 G, modulation frequency 100 kHz, microwave power 0.3 mW, temperature 5.0 K. For ICP-MS, sample 
was treated with nitric acid 65% and measured in an Agilent 7500 ICP-MS (Agilent technologies, UK). The equip-
ment was fitted with an auto sampler (ASX-500 series), a quartz double-pass spray chamber (Peltier-cooled, 
Scott-type), a concentric MicroMist nebuliser and a third generation Octopole Reaction System (ORS3). This 
allows for the correction of spectral interferences by the addition of He or H2 gas to the collision cell, producing 
ions of a lower kinetic energy that enable the analyte ions with a higher energy than the multipole to be transmit-
ted to the mass analyser. The digested sample solution was added via a T-piece before nebulisation, along with the 
internal standard solution. Ion standards are made up from single stocks and mixed element standards supplied 
by VWR and Johnson Matthey.
Inhibition assays. The IC50 of 2-phospho-L-ascorbic acid (2P-AC) and L-ascorbic acid (L-AC) was determined 
using a 150 µl reaction mixture containing 0.5 µg of protein in 50 mM Tris-Base, 150 mM NaCl, pH 7.5 and the different 
inhibitors (0.02 µM–20 mM). The reaction was incubated for 30 min at room temperature, followed by the addition of 
pNPP to a final concentration equal to its Km value and incubated for 30 min at 37 °C. The reaction was quenched by 
adding 50 µl of NaOH 1 M to measure absorbance at 405 nm. The concentration of p-nitrophenol produced was deter-
mined using a p-nitrophenol standard curve and expressed as a percentage of the specific activity. Data was plotted as a 
function of log inhibitor concentration to calculate the IC50 using a four-parameter dose-response curve in GraphPad 
Prism 7.01. Selectivity assays for MptpA and MptpB were done by determining specific activity towards pNPP in the 
presence of 4 mM 2P-AC in a reaction assay containing 5 µg of protein, 50 mM Tris-Base, 50 mM Bis-Tris, 100 mM 
Sodium Acetate, pH 6 and incubating for 30 min at room temperature.
To determine the type of inhibition of 2P-AC and L-AC, different inhibitor concentrations were used (for L-AC 
146 µM, 243 µM and 365 µM; for 2P-AC 140 µM, 234 µM and 351 µM) in a 150 µl reaction mixture containing 0.5 µg of 
protein in 50 mM Tris-Base, 150 mM NaCl, pH 7.5. Samples were incubated for 30 min at room temperature, followed 
by addition of different concentrations of pNPP (62.5 µM, 125 µM, 250 µM, 500 µM, 1 mM and 2 mM) and further 
incubated for 30 min at 37 °C. The reaction was quenched by adding 50 µl of NaOH 1 M. Velocity (V) was plotted as a 
function of pNPP concentration and fit in a Lineweaver-Burk plot (double-reciprocal) using GraphPad Prism 7.01. All 
the experiments were performed in triplicates in at least two separate studies.
Cell and bacterial culture conditions. THP1 macrophages cells (ATCC) were cultured in Roswell Park 
Memorial Institute-1640 medium (RPMI-1640) (R8758-Sigma-Aldrich) containing L-glutamine supplemented 
with 10% heat inactivated fetal bovine serum (FBS, Invitrogen) at 37 °C in a 5% CO2. M. tuberculosis (Mtb) labo-
ratory strain H37Rv was grown on Middlebrook 7H9 broth (BD Diagnostics) at 37 °C in 5% CO2 or Middlebrook 
7H10 agar (both mediums were supplemented with 0.05% Tween 80, 0.2% glycerol and 10% OADC). Mtb 
cultures were prepared using 1 ml of mid-log phase stock into 20 ml of fresh media and incubated static for 6 
days prior to being used in infection assays or inhibitory assays. All experiments with Mtb were carried out in a 
biosafety level 3 containment facility.
extracellular growth of Mycobacterium tuberculosis  and macrophage infections. 
2-phospho-L-ascorbic acid (2P-AC) and L-ascorbic acid (L-AC) effect on extracellular cultures of Mtb was 
assessed by adding 1 mM or 4 mM of the compounds in 20 ml of Middlebrook 7H9 broth. Compounds were 
added to the culture in day 0 and 1 and allowed to grow over 11 days. Mycobacterial growth was monitored by 
optical density (OD) at 600 nm. Experiments were performed in triplicates in at least two separate studies. For 
statistical analyses, OD values were evaluated by two-way ANOVA followed by a multiple comparison analyses of 
variance by Bonferroni test (GraphPad Prism 7.01 for Windows). Differences were considered significant at the 
95% level of confidence.
For the macrophage infections, THP1 cells were seeded in 24-well culture plates (Corning) at a density of 1 × 105 
cells per well (in 500 µl media) and treated with 200 nM PMA for 2 h. After treatment, media was changed for fresh 
RPMI (with 10% FBS) overnight. The following day, media was removed and cells were washed with PBS and 500 µl 
of fresh RPMI was added containing 2P-AC (1 mM and 4 mM dissolved in water) before infecting the cells with Mtb 
at MOI of 5:1 (bacteria:macrophage). After 4 h of infection, THP1 cells were washed three times with Dulbecco’s PBS 
and fresh RPMI was added containing 2P-AC. After 24 h the media was removed and cells were washed twice with 
PBS prior to the addition of RPMI containing 2P-AC. At 72 h post infection cells were lysed with ice-cold water and 
plated onto 7H10 agar. Colonies were counted after 14 days. All experimental points were plated as 10-fold dilutions in 
triplicates. Each sample was setup in triplicates in at least two independent experiments. For statistical analyses, CFU/
ml values were evaluated by one-way ANOVA followed by a multiple comparison analyses of variance by Bonferroni 
test (GraphPad Prism 7.01 for Windows). Differences were considered significant at the 95% level of confidence. All 
experiments with Mtb were carried out in a biosafety level 3 containment facility.
Cytotoxicity assays. MTT assay was performed as described previously61. Briefly, THP1 cells were seeded 
in 96-well culture plates (Corning) at a density of 5 × 104 (in 200 μl media) and treated with 200 nM PMA for 
2 h. After treatment, media was changed for fresh RPMI (with 1% FBS) and leaved it overnight. The following 
day media was removed and fresh RPMI was added supplemented with 2P-AC inhibitor. Inhibitor was added to 
each well at 0 h and 24 h. After 48 h, cells were washed once with PBS and 200 μl of fresh RPMI was added. At 
72 h, media was removed and changed for 200 μl of fresh RPMI. Cell viability was assessed by adding 50 µl of filter 
sterilised MTT (5 mg/ml in PBS) to each well followed by a 2 h incubation period at 37 °C in a 5% CO2. Media 
was removed and the blue formazan crystals trapped in cells were dissolved by adding 200 µl of DMSO and 25 µl 
of Sorensen’s glycine buffer. The absorbance at 570 nm was measured in a plate reader. Each sample was setup in 
triplicates in at least two independent experiments.
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